BioIVT Launches New Website, Highlighting Expanded Biospecimen Product and Service Portfolios for Drug Development Researchers

Website also sports new scientific resources, streamlined navigation, and enhanced search functionality.

Westbury, NY – BioIVT, a leading provider of biospecimens and related services, today announced the launch of its comprehensive, new, user-friendly website at www.bioivt.com. This launch coincides with the introduction of BioIVT’s new logo and marks the culmination of its new brand rollout.

“BioIVT has greatly expanded its product and service portfolios during the past few months with its acquisitions of Asterand Bioscience™ and Qualyst Transporter Solutions in August 2017 and September, 2017, respectively,” said Courtney Noah, PhD, BioIVT Vice President of Marketing. “We developed this new company website to share our vision, display our entire range of biospecimen and value-added service offerings in one place, and demonstrate new ways in which we can partner with drug researchers to elevate science.”

The new BioIVT website is divided into four sections, each representing an industry that the company serves – Drug Discovery/Development, Diagnostics Development, Consumer Goods/Personal Care, and Ag/Chemical – and highlighting ways in which it can support customers in that market segment. In addition, each BioIVT product and service has a dedicated website page, detailing all its features and customer benefits.

The company’s newly-expanded PHASEZERO® Research Services team – which provides a combination of Asterand and Qualyst services – now offers research solutions ranging from target validation through to clinical assay development. Thus, it can help researchers to assess the safety and efficacy of new therapeutics throughout the drug development continuum.

In addition, the new user-friendly BioIVT website serves as a destination for scientific resources such as case studies and application notes, protocols and tutorials, brochures, posters, and webinars.

From a hands-on perspective, it also offers more streamlined navigation and enhanced search functionality. Customers can now quickly review BioIVT products and services based on their disease focus or application area, and request a custom quote if required.

About BioIVT

BioIVT, formerly BioreclamationIVT, is a leading global provider of high-quality biological specimens and value-added services. We specialize in control and disease-state samples including human and animal tissues, cell products, blood and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples. Our PHASEZERO® Research Services team works collaboratively with clients to provide target and biomarker validation, phenotypic assays to characterize novel therapeutics, clinical assay development and in vitro hepatic modeling solutions. And as the premier supplier of ADME-toxicology model systems, including hepatocytes and subcellular fractions, BioIVT enables scientists to better understand the pharmacokinetics and drug metabolism of newly-discovered compounds and their effects on disease processes. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in elevating science. For more information, please visit www.bioivt.com or follow the company on Twitter @BioIVT.

BioIVT Contact: Courtney Noah, Vice President of Marketing, 516-483-1196

Media Contact: Lisa Osborne, Rana Healthcare Solutions, 206-992-5245, lisa@ranahealth.com